LU83865A1 - Pyrido(1,4)benzodiazepines phenyl-substituees et leurs intermediaires,utiles comme medicaments antidepresseurs - Google Patents
Pyrido(1,4)benzodiazepines phenyl-substituees et leurs intermediaires,utiles comme medicaments antidepresseurs Download PDFInfo
- Publication number
- LU83865A1 LU83865A1 LU83865A LU83865A LU83865A1 LU 83865 A1 LU83865 A1 LU 83865A1 LU 83865 A LU83865 A LU 83865A LU 83865 A LU83865 A LU 83865A LU 83865 A1 LU83865 A1 LU 83865A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- pyrido
- phenyl
- compound according
- amino
- benzodiazepine
- Prior art date
Links
- 229940049706 benzodiazepine Drugs 0.000 title claims description 48
- 239000000543 intermediate Substances 0.000 title description 34
- 239000000935 antidepressant agent Substances 0.000 title description 11
- 229940005513 antidepressants Drugs 0.000 title description 10
- 230000001430 anti-depressive effect Effects 0.000 title description 5
- 150000001557 benzodiazepines Chemical class 0.000 title description 5
- 229940126601 medicinal product Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 152
- -1 1-piperazinyl Chemical group 0.000 claims description 119
- 229910052757 nitrogen Inorganic materials 0.000 claims description 84
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 59
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 51
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 42
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 42
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 claims description 39
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- 239000002253 acid Substances 0.000 claims description 25
- GUJAGMICFDYKNR-UHFFFAOYSA-N 1,4-benzodiazepine Chemical compound N1C=CN=CC2=CC=CC=C12 GUJAGMICFDYKNR-UHFFFAOYSA-N 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 18
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 16
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 claims description 12
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 11
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 10
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims description 8
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 8
- WUFWBVLAMURTLR-UHFFFAOYSA-N 6-phenyl-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound N=1C2=CC=CN=C2NC2=CC=CC=C2C=1C1=CC=CC=C1 WUFWBVLAMURTLR-UHFFFAOYSA-N 0.000 claims description 8
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 claims description 6
- UUBJKHVFGWGJKX-UHFFFAOYSA-N hydrate tetrahydrochloride Chemical compound O.Cl.Cl.Cl.Cl UUBJKHVFGWGJKX-UHFFFAOYSA-N 0.000 claims description 6
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 6
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 6
- 125000004076 pyridyl group Chemical group 0.000 claims description 6
- PRSVNUAKIMADLF-UHFFFAOYSA-N 3-(6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)propan-1-amine Chemical compound N=1C2=CC=CN=C2N(CCCN)C2=CC=CC=C2C=1C1=CC=CC=C1 PRSVNUAKIMADLF-UHFFFAOYSA-N 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 5
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 4
- 208000020401 Depressive disease Diseases 0.000 claims description 4
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims description 3
- OCWGEIWZCDZNQX-UHFFFAOYSA-N 8-chloro-6-(2-chlorophenyl)-6,11-dihydro-5h-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C12=CC(Cl)=CC=C2NC2=NC=CC=C2NC1C1=CC=CC=C1Cl OCWGEIWZCDZNQX-UHFFFAOYSA-N 0.000 claims description 3
- OJNKGLCGQGJFRJ-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(3-chlorophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CC(Cl)=C1 OJNKGLCGQGJFRJ-UHFFFAOYSA-N 0.000 claims description 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 3
- 125000004494 ethyl ester group Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- GEASQYOWLOGKQJ-UHFFFAOYSA-N 3-[6-(3-chlorophenyl)pyrido[2,3-b][1,4]benzodiazepin-11-yl]-n,n-dimethylpropan-1-amine Chemical compound N=1C2=CC=CN=C2N(CCCN(C)C)C2=CC=CC=C2C=1C1=CC=CC(Cl)=C1 GEASQYOWLOGKQJ-UHFFFAOYSA-N 0.000 claims description 2
- WYXAIBNXRSGGRD-UHFFFAOYSA-N 8-chloro-11-methyl-6-phenylpyrido[2,3-b][1,4]benzodiazepine Chemical compound N=1C2=CC=CN=C2N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 WYXAIBNXRSGGRD-UHFFFAOYSA-N 0.000 claims description 2
- WQOTZBOEOBUZRP-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-3-chlorophenyl]-phenylmethanone Chemical compound NC1=CC=CN=C1NC1=C(Cl)C=CC=C1C(=O)C1=CC=CC=C1 WQOTZBOEOBUZRP-UHFFFAOYSA-N 0.000 claims description 2
- DTSZGOYWJREPIZ-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-5-chlorophenyl]-(2-chlorophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=C(Cl)C=C1C(=O)C1=CC=CC=C1Cl DTSZGOYWJREPIZ-UHFFFAOYSA-N 0.000 claims description 2
- 125000005605 benzo group Chemical group 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 2
- BLNWTAHYTCHDJH-UHFFFAOYSA-O hydroxy(oxo)azanium Chemical compound O[NH+]=O BLNWTAHYTCHDJH-UHFFFAOYSA-O 0.000 claims 2
- KMNNBLWDPHEJGU-VQHVLOKHSA-N (E)-2-(1H-1,2-benzodiazepin-3-yl)but-2-enedioic acid Chemical compound C1=CC=C2C(=C1)C=CC(=NN2)/C(=C\C(=O)O)/C(=O)O KMNNBLWDPHEJGU-VQHVLOKHSA-N 0.000 claims 1
- 125000001207 fluorophenyl group Chemical group 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 239000002547 new drug Substances 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 267
- 239000000203 mixture Substances 0.000 description 110
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 99
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 78
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 72
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 61
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 51
- 238000004458 analytical method Methods 0.000 description 45
- 238000000034 method Methods 0.000 description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
- 239000000047 product Substances 0.000 description 39
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 38
- 239000011541 reaction mixture Substances 0.000 description 36
- 239000000284 extract Substances 0.000 description 34
- 229940050411 fumarate Drugs 0.000 description 34
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- 239000000243 solution Substances 0.000 description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 32
- 239000007787 solid Substances 0.000 description 29
- 239000002904 solvent Substances 0.000 description 28
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
- 229910000104 sodium hydride Inorganic materials 0.000 description 27
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 26
- 239000012312 sodium hydride Substances 0.000 description 26
- 239000000725 suspension Substances 0.000 description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- NDYMQOUYJJXCKJ-UHFFFAOYSA-N (4-fluorophenyl)-morpholin-4-ylmethanone Chemical compound C1=CC(F)=CC=C1C(=O)N1CCOCC1 NDYMQOUYJJXCKJ-UHFFFAOYSA-N 0.000 description 23
- 238000001914 filtration Methods 0.000 description 21
- 239000012458 free base Substances 0.000 description 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 19
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 19
- 235000019341 magnesium sulphate Nutrition 0.000 description 19
- MEQBJJUWDCYIAB-UHFFFAOYSA-N 2-chloropyridin-3-amine Chemical compound NC1=CC=CN=C1Cl MEQBJJUWDCYIAB-UHFFFAOYSA-N 0.000 description 18
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 18
- 125000001309 chloro group Chemical group Cl* 0.000 description 18
- 238000010992 reflux Methods 0.000 description 18
- 238000003756 stirring Methods 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 16
- 235000019441 ethanol Nutrition 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 15
- 239000012299 nitrogen atmosphere Substances 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 239000004480 active ingredient Substances 0.000 description 14
- CJHKJXZMFZKGHI-UHFFFAOYSA-N 1h-pyrido[2,3-i][1,2]benzodiazepine Chemical class N1N=CC=CC2=CC=C(N=CC=C3)C3=C12 CJHKJXZMFZKGHI-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 238000001035 drying Methods 0.000 description 12
- 239000002480 mineral oil Substances 0.000 description 12
- 235000010446 mineral oil Nutrition 0.000 description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 12
- 239000002775 capsule Substances 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- LJQNMDZRCXJETK-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine;hydron;chloride Chemical compound Cl.CN(C)CCCCl LJQNMDZRCXJETK-UHFFFAOYSA-N 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- 150000003254 radicals Chemical class 0.000 description 10
- 238000001953 recrystallisation Methods 0.000 description 10
- 239000001530 fumaric acid Substances 0.000 description 9
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 9
- 238000004809 thin layer chromatography Methods 0.000 description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 7
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical class O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 125000001246 bromo group Chemical group Br* 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 239000008101 lactose Substances 0.000 description 6
- LEVJVKGPFAQPOI-UHFFFAOYSA-N phenylmethanone Chemical compound O=[C]C1=CC=CC=C1 LEVJVKGPFAQPOI-UHFFFAOYSA-N 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000012258 stirred mixture Substances 0.000 description 6
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000000638 solvent extraction Methods 0.000 description 5
- MAOBFOXLCJIFLV-UHFFFAOYSA-N (2-aminophenyl)-phenylmethanone Chemical class NC1=CC=CC=C1C(=O)C1=CC=CC=C1 MAOBFOXLCJIFLV-UHFFFAOYSA-N 0.000 description 4
- MNXYYAMZMWCDQR-UHFFFAOYSA-N 8-chloro-6-phenyl-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C12=CC(Cl)=CC=C2NC2=NC=CC=C2N=C1C1=CC=CC=C1 MNXYYAMZMWCDQR-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 238000000262 chemical ionisation mass spectrometry Methods 0.000 description 4
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 3
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 3
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000011260 aqueous acid Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- GEVPUGOOGXGPIO-UHFFFAOYSA-N oxalic acid;dihydrate Chemical compound O.O.OC(=O)C(O)=O GEVPUGOOGXGPIO-UHFFFAOYSA-N 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- ZUWXHHBROGLWNH-UHFFFAOYSA-N (2-amino-5-chlorophenyl)-phenylmethanone Chemical compound NC1=CC=C(Cl)C=C1C(=O)C1=CC=CC=C1 ZUWXHHBROGLWNH-UHFFFAOYSA-N 0.000 description 2
- APHLSUBLNQBFTM-UHFFFAOYSA-N (2-aminophenyl)-(4-chlorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=C(Cl)C=C1 APHLSUBLNQBFTM-UHFFFAOYSA-N 0.000 description 2
- MKJIEFSOBYUXJB-HOCLYGCPSA-N (3S,11bS)-9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one Chemical compound C1CN2C[C@H](CC(C)C)C(=O)C[C@H]2C2=C1C=C(OC)C(OC)=C2 MKJIEFSOBYUXJB-HOCLYGCPSA-N 0.000 description 2
- RYCQVMPEIVZMII-UHFFFAOYSA-N 11h-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C1=NC2=CC=CN=C2NC2=CC=CC=C21 RYCQVMPEIVZMII-UHFFFAOYSA-N 0.000 description 2
- HPYNZHMRTTWQTB-UHFFFAOYSA-N 2,3-dimethylpyridine Chemical compound CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 2
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 2
- LQLJZSJKRYTKTP-UHFFFAOYSA-N 2-dimethylaminoethyl chloride hydrochloride Chemical compound Cl.CN(C)CCCl LQLJZSJKRYTKTP-UHFFFAOYSA-N 0.000 description 2
- RZJPBQGRCNJYBU-UHFFFAOYSA-N 3-chloropyridin-2-amine Chemical compound NC1=NC=CC=C1Cl RZJPBQGRCNJYBU-UHFFFAOYSA-N 0.000 description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 2
- GTLFLMZOABSJSV-UHFFFAOYSA-N 4-chloropyridin-3-amine Chemical compound NC1=CN=CC=C1Cl GTLFLMZOABSJSV-UHFFFAOYSA-N 0.000 description 2
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 2
- XLWJZKAGAQBOPY-UHFFFAOYSA-N 6-phenyl-11H-pyrido[4,3-b][1,4]benzodiazepine Chemical compound C1(=CC=CC=C1)C1=NC2=C(NC3=C1C=CC=C3)C=CN=C2 XLWJZKAGAQBOPY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- 206010015995 Eyelid ptosis Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HYJMLOKGGXFNQY-UHFFFAOYSA-N [2-[(3-amino-2-methylpyridin-4-yl)amino]phenyl]-phenylmethanone Chemical compound CC1=NC=CC(NC=2C(=CC=CC=2)C(=O)C=2C=CC=CC=2)=C1N HYJMLOKGGXFNQY-UHFFFAOYSA-N 0.000 description 2
- QOZBLGCNXCXFFL-UHFFFAOYSA-N [2-[(3-amino-5-methylpyridin-2-yl)amino]phenyl]-phenylmethanone Chemical compound NC1=CC(C)=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1 QOZBLGCNXCXFFL-UHFFFAOYSA-N 0.000 description 2
- WEQVXKNDOVQCSD-UHFFFAOYSA-N [2-[(3-amino-6-methoxypyridin-2-yl)amino]phenyl]-phenylmethanone Chemical compound COC1=CC=C(N)C(NC=2C(=CC=CC=2)C(=O)C=2C=CC=CC=2)=N1 WEQVXKNDOVQCSD-UHFFFAOYSA-N 0.000 description 2
- CXSUXRCWFYTDAF-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-4-nitrophenyl]-phenylmethanone Chemical compound NC1=CC=CN=C1NC1=CC([N+]([O-])=O)=CC=C1C(=O)C1=CC=CC=C1 CXSUXRCWFYTDAF-UHFFFAOYSA-N 0.000 description 2
- QYDGGUAEVOVCHM-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(2,4-dichlorophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=C(Cl)C=C1Cl QYDGGUAEVOVCHM-UHFFFAOYSA-N 0.000 description 2
- HGZDETKBNOINJD-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(2-bromophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1Br HGZDETKBNOINJD-UHFFFAOYSA-N 0.000 description 2
- NZJYWIQIHUSNGV-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(2-chlorophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1Cl NZJYWIQIHUSNGV-UHFFFAOYSA-N 0.000 description 2
- GIUVDXKBPBEEHB-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(2-ethylphenyl)methanone Chemical compound CCC1=CC=CC=C1C(=O)C1=CC=CC=C1NC1=NC=CC=C1N GIUVDXKBPBEEHB-UHFFFAOYSA-N 0.000 description 2
- MHFOVOQDIBGHFA-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(2-fluorophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1F MHFOVOQDIBGHFA-UHFFFAOYSA-N 0.000 description 2
- HSDPBZAVKFMNRG-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(2-nitrophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1[N+]([O-])=O HSDPBZAVKFMNRG-UHFFFAOYSA-N 0.000 description 2
- AHPZPYCUCRJXBX-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(3-ethylphenyl)methanone Chemical compound CCC1=CC=CC(C(=O)C=2C(=CC=CC=2)NC=2C(=CC=CN=2)N)=C1 AHPZPYCUCRJXBX-UHFFFAOYSA-N 0.000 description 2
- SMYWETHWEVUJTI-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(4-ethoxyphenyl)methanone Chemical compound C1=CC(OCC)=CC=C1C(=O)C1=CC=CC=C1NC1=NC=CC=C1N SMYWETHWEVUJTI-UHFFFAOYSA-N 0.000 description 2
- AOVSJTFJRDMYEH-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(4-ethylphenyl)methanone Chemical compound C1=CC(CC)=CC=C1C(=O)C1=CC=CC=C1NC1=NC=CC=C1N AOVSJTFJRDMYEH-UHFFFAOYSA-N 0.000 description 2
- SCGDWNNMIJKUCB-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(4-nitrophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=C([N+]([O-])=O)C=C1 SCGDWNNMIJKUCB-UHFFFAOYSA-N 0.000 description 2
- QXDDZNMTJIFLSF-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(4-propan-2-ylphenyl)methanone Chemical compound C1=CC(C(C)C)=CC=C1C(=O)C1=CC=CC=C1NC1=NC=CC=C1N QXDDZNMTJIFLSF-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 229940059260 amidate Drugs 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000000451 chemical ionisation Methods 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000002576 diazepinyl group Chemical class N1N=C(C=CC=C1)* 0.000 description 2
- 150000008533 dibenzodiazepines Chemical group 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 229940071870 hydroiodic acid Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- ROVQCXKNBAJXAZ-UHFFFAOYSA-N n-methyl-3-(6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)propan-1-amine Chemical compound N=1C2=CC=CN=C2N(CCCNC)C2=CC=CC=C2C=1C1=CC=CC=C1 ROVQCXKNBAJXAZ-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 125000005544 phthalimido group Chemical group 0.000 description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- 201000003004 ptosis Diseases 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 229960005333 tetrabenazine Drugs 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- FBWIBFRRBJHQTK-UHFFFAOYSA-N (2-amino-3-methylphenyl)-phenylmethanone Chemical compound CC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1N FBWIBFRRBJHQTK-UHFFFAOYSA-N 0.000 description 1
- NPOSTKZYBVQXNJ-UHFFFAOYSA-N (2-amino-4-bromophenyl)-phenylmethanone Chemical compound NC1=CC(Br)=CC=C1C(=O)C1=CC=CC=C1 NPOSTKZYBVQXNJ-UHFFFAOYSA-N 0.000 description 1
- PELAWRHVRDOWQT-UHFFFAOYSA-N (2-amino-4-chlorophenyl)-phenylmethanone Chemical compound NC1=CC(Cl)=CC=C1C(=O)C1=CC=CC=C1 PELAWRHVRDOWQT-UHFFFAOYSA-N 0.000 description 1
- SZCJXVHNJARLED-UHFFFAOYSA-N (2-amino-4-ethoxyphenyl)-phenylmethanone Chemical compound NC1=CC(OCC)=CC=C1C(=O)C1=CC=CC=C1 SZCJXVHNJARLED-UHFFFAOYSA-N 0.000 description 1
- UKDUKOFRZJFFGG-UHFFFAOYSA-N (2-amino-4-ethylphenyl)-phenylmethanone Chemical compound NC1=CC(CC)=CC=C1C(=O)C1=CC=CC=C1 UKDUKOFRZJFFGG-UHFFFAOYSA-N 0.000 description 1
- UJUNEYQAFREPBB-UHFFFAOYSA-N (2-amino-4-fluorophenyl)-phenylmethanone Chemical compound NC1=CC(F)=CC=C1C(=O)C1=CC=CC=C1 UJUNEYQAFREPBB-UHFFFAOYSA-N 0.000 description 1
- YINYAGBOKBLJHY-UHFFFAOYSA-N (2-amino-4-methylphenyl)-phenylmethanone Chemical compound NC1=CC(C)=CC=C1C(=O)C1=CC=CC=C1 YINYAGBOKBLJHY-UHFFFAOYSA-N 0.000 description 1
- KWZYIAJRFJVQDO-UHFFFAOYSA-N (2-amino-5-chlorophenyl)-(2-chlorophenyl)methanone Chemical compound NC1=CC=C(Cl)C=C1C(=O)C1=CC=CC=C1Cl KWZYIAJRFJVQDO-UHFFFAOYSA-N 0.000 description 1
- MZPDVYDLHYUTQS-UHFFFAOYSA-N (2-amino-5-methylphenyl)-phenylmethanone Chemical compound CC1=CC=C(N)C(C(=O)C=2C=CC=CC=2)=C1 MZPDVYDLHYUTQS-UHFFFAOYSA-N 0.000 description 1
- IQHIGDFLXBHMCV-UHFFFAOYSA-N (2-amino-6-chlorophenyl)-phenylmethanone Chemical compound NC1=CC=CC(Cl)=C1C(=O)C1=CC=CC=C1 IQHIGDFLXBHMCV-UHFFFAOYSA-N 0.000 description 1
- ZKUPQLDSYHOFTE-UHFFFAOYSA-N (2-amino-6-methylphenyl)-phenylmethanone Chemical compound CC1=CC=CC(N)=C1C(=O)C1=CC=CC=C1 ZKUPQLDSYHOFTE-UHFFFAOYSA-N 0.000 description 1
- KIQAJJIMMVVAOZ-UHFFFAOYSA-N (2-aminophenyl)-(2,4-dichlorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=C(Cl)C=C1Cl KIQAJJIMMVVAOZ-UHFFFAOYSA-N 0.000 description 1
- DPWZTVFFYVPPHU-UHFFFAOYSA-N (2-aminophenyl)-(2-bromophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1Br DPWZTVFFYVPPHU-UHFFFAOYSA-N 0.000 description 1
- PKSVTEMCGNQIMD-UHFFFAOYSA-N (2-aminophenyl)-(2-chlorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1Cl PKSVTEMCGNQIMD-UHFFFAOYSA-N 0.000 description 1
- XTFBFWHLRDDEHC-UHFFFAOYSA-N (2-aminophenyl)-(2-ethylphenyl)methanone Chemical compound CCC1=CC=CC=C1C(=O)C1=CC=CC=C1N XTFBFWHLRDDEHC-UHFFFAOYSA-N 0.000 description 1
- NRAJMXHXQHCBHO-UHFFFAOYSA-N (2-aminophenyl)-(2-fluorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1F NRAJMXHXQHCBHO-UHFFFAOYSA-N 0.000 description 1
- YWMIKJZVOJLVMB-UHFFFAOYSA-N (2-aminophenyl)-(2-methoxyphenyl)methanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC=CC=C1N YWMIKJZVOJLVMB-UHFFFAOYSA-N 0.000 description 1
- ASDIDCKLLOQMSN-UHFFFAOYSA-N (2-aminophenyl)-(2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1C(=O)C1=CC=CC=C1N ASDIDCKLLOQMSN-UHFFFAOYSA-N 0.000 description 1
- PMBOBOCOXFKIAG-UHFFFAOYSA-N (2-aminophenyl)-(2-nitrophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1[N+]([O-])=O PMBOBOCOXFKIAG-UHFFFAOYSA-N 0.000 description 1
- COMTXRHVBLIIOW-UHFFFAOYSA-N (2-aminophenyl)-(3-chlorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC(Cl)=C1 COMTXRHVBLIIOW-UHFFFAOYSA-N 0.000 description 1
- IHVWWFCAVGFAGI-UHFFFAOYSA-N (2-aminophenyl)-(3-ethoxyphenyl)methanone Chemical compound CCOC1=CC=CC(C(=O)C=2C(=CC=CC=2)N)=C1 IHVWWFCAVGFAGI-UHFFFAOYSA-N 0.000 description 1
- AJQKCZXOPAOQJC-UHFFFAOYSA-N (2-aminophenyl)-(3-ethylphenyl)methanone Chemical compound CCC1=CC=CC(C(=O)C=2C(=CC=CC=2)N)=C1 AJQKCZXOPAOQJC-UHFFFAOYSA-N 0.000 description 1
- GPJUYTLMEAYQSS-UHFFFAOYSA-N (2-aminophenyl)-(3-fluorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC(F)=C1 GPJUYTLMEAYQSS-UHFFFAOYSA-N 0.000 description 1
- OMQSFYCLALWVOF-UHFFFAOYSA-N (2-aminophenyl)-(3-methylphenyl)methanone Chemical compound CC1=CC=CC(C(=O)C=2C(=CC=CC=2)N)=C1 OMQSFYCLALWVOF-UHFFFAOYSA-N 0.000 description 1
- WIISOMGJWLLMDG-UHFFFAOYSA-N (2-aminophenyl)-(4-bromophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=C(Br)C=C1 WIISOMGJWLLMDG-UHFFFAOYSA-N 0.000 description 1
- GZZWLEWVEIKCOX-UHFFFAOYSA-N (2-aminophenyl)-(4-ethoxyphenyl)methanone Chemical compound C1=CC(OCC)=CC=C1C(=O)C1=CC=CC=C1N GZZWLEWVEIKCOX-UHFFFAOYSA-N 0.000 description 1
- NPBPXTOTUGBXDW-UHFFFAOYSA-N (2-aminophenyl)-(4-ethylphenyl)methanone Chemical compound C1=CC(CC)=CC=C1C(=O)C1=CC=CC=C1N NPBPXTOTUGBXDW-UHFFFAOYSA-N 0.000 description 1
- FFFXIQFESQNINT-UHFFFAOYSA-N (2-aminophenyl)-(4-fluorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=C(F)C=C1 FFFXIQFESQNINT-UHFFFAOYSA-N 0.000 description 1
- FLORUWDSYNSEAH-UHFFFAOYSA-N (2-aminophenyl)-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1N FLORUWDSYNSEAH-UHFFFAOYSA-N 0.000 description 1
- RMMJUQSANCPTMV-UHFFFAOYSA-N (2-aminophenyl)-(4-methylphenyl)methanone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC=C1N RMMJUQSANCPTMV-UHFFFAOYSA-N 0.000 description 1
- CKCNELPOXRQRDT-UHFFFAOYSA-N (2-aminophenyl)-(4-nitrophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=C([N+]([O-])=O)C=C1 CKCNELPOXRQRDT-UHFFFAOYSA-N 0.000 description 1
- LHGJXKURFVAMEG-UHFFFAOYSA-N (2-aminophenyl)-(4-propan-2-ylphenyl)methanone Chemical compound C1=CC(C(C)C)=CC=C1C(=O)C1=CC=CC=C1N LHGJXKURFVAMEG-UHFFFAOYSA-N 0.000 description 1
- WEWXXYDHYCDEKY-UHFFFAOYSA-N (2-aminophenyl)-pyridin-2-ylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=N1 WEWXXYDHYCDEKY-UHFFFAOYSA-N 0.000 description 1
- KNZLZNHWLVEHCZ-UHFFFAOYSA-N (2-aminophenyl)-pyridin-3-ylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CN=C1 KNZLZNHWLVEHCZ-UHFFFAOYSA-N 0.000 description 1
- MOPYXHGIWARXCY-UHFFFAOYSA-N (2-aminophenyl)-pyridin-4-ylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=NC=C1 MOPYXHGIWARXCY-UHFFFAOYSA-N 0.000 description 1
- LRZCHOZJGIXTRX-UHFFFAOYSA-N (2-aminophenyl)-thiophen-2-ylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CS1 LRZCHOZJGIXTRX-UHFFFAOYSA-N 0.000 description 1
- VUMAJNCFORYAML-UHFFFAOYSA-N (2-aminophenyl)-thiophen-3-ylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CSC=C1 VUMAJNCFORYAML-UHFFFAOYSA-N 0.000 description 1
- JKHSRNYPTRPVMS-UHFFFAOYSA-N (2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1[C+]=O JKHSRNYPTRPVMS-UHFFFAOYSA-N 0.000 description 1
- LRANPJDWHYRCER-UHFFFAOYSA-N 1,2-diazepine Chemical compound N1C=CC=CC=N1 LRANPJDWHYRCER-UHFFFAOYSA-N 0.000 description 1
- OBOBUDMMFXRNDO-UHFFFAOYSA-N 1-(3-chloropropyl)piperidine;hydron;chloride Chemical compound Cl.ClCCCN1CCCCC1 OBOBUDMMFXRNDO-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- YXMZQCOIZKNSJL-UHFFFAOYSA-N 11-[3-(dimethylamino)propyl]-6-phenylpyrido[2,3-b][1,4]benzodiazepin-3-ol Chemical compound N=1C2=CC(O)=CN=C2N(CCCN(C)C)C2=CC=CC=C2C=1C1=CC=CC=C1 YXMZQCOIZKNSJL-UHFFFAOYSA-N 0.000 description 1
- OPACCTXYZFTUOQ-UHFFFAOYSA-N 1h-pyrido[2,3-i][1,4]benzodiazepine Chemical class N1C=CN=CC2=CC=C(N=CC=C3)C3=C12 OPACCTXYZFTUOQ-UHFFFAOYSA-N 0.000 description 1
- QHYXWSXPPUTDRA-UHFFFAOYSA-N 2,3-dihydro-1h-diazepine Chemical compound C1NNC=CC=C1 QHYXWSXPPUTDRA-UHFFFAOYSA-N 0.000 description 1
- BZSXWKWQGXRMOX-UHFFFAOYSA-N 2,3-dimethyl-6-phenyl-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C12=CC=CC=C2NC=2N=C(C)C(C)=CC=2N=C1C1=CC=CC=C1 BZSXWKWQGXRMOX-UHFFFAOYSA-N 0.000 description 1
- VKJCJJYNVIYVQR-UHFFFAOYSA-N 2-(3-bromopropyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCCBr)C(=O)C2=C1 VKJCJJYNVIYVQR-UHFFFAOYSA-N 0.000 description 1
- HEGDBOGOOIDODY-UHFFFAOYSA-N 2-(8-chloro-6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)-n,n-dimethylethanamine Chemical compound N=1C2=CC=CN=C2N(CCN(C)C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 HEGDBOGOOIDODY-UHFFFAOYSA-N 0.000 description 1
- YFQVSTNNJZZYLY-UHFFFAOYSA-N 2-amino-4,6-diphenylpyridine-3-carbonitrile Chemical compound N#CC=1C(N)=NC(C=2C=CC=CC=2)=CC=1C1=CC=CC=C1 YFQVSTNNJZZYLY-UHFFFAOYSA-N 0.000 description 1
- UOBCYTOUXLAABU-UHFFFAOYSA-N 2-chloro-4-methylpyridin-3-amine Chemical compound CC1=CC=NC(Cl)=C1N UOBCYTOUXLAABU-UHFFFAOYSA-N 0.000 description 1
- WAUIZPNNOVYVBV-UHFFFAOYSA-N 2-chloro-5,6-dimethylpyridin-3-amine Chemical compound CC1=CC(N)=C(Cl)N=C1C WAUIZPNNOVYVBV-UHFFFAOYSA-N 0.000 description 1
- CQKIBEOVARIBDN-UHFFFAOYSA-N 2-chloro-5-methylpyridin-3-amine Chemical compound CC1=CN=C(Cl)C(N)=C1 CQKIBEOVARIBDN-UHFFFAOYSA-N 0.000 description 1
- AOGGRVIJAHZLFK-UHFFFAOYSA-N 2-chloro-6-methoxypyridin-3-amine Chemical compound COC1=CC=C(N)C(Cl)=N1 AOGGRVIJAHZLFK-UHFFFAOYSA-N 0.000 description 1
- SUMSBUDMYMYTLL-UHFFFAOYSA-N 2-chloro-6-methylpyridin-3-amine Chemical compound CC1=CC=C(N)C(Cl)=N1 SUMSBUDMYMYTLL-UHFFFAOYSA-N 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- BJSFITYHGLDVFE-UHFFFAOYSA-N 3-(9-chloro-6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)-n,n-dimethylpropan-1-amine Chemical compound N=1C2=CC=CN=C2N(CCCN(C)C)C2=CC(Cl)=CC=C2C=1C1=CC=CC=C1 BJSFITYHGLDVFE-UHFFFAOYSA-N 0.000 description 1
- QHTMOFKGJVMAAW-UHFFFAOYSA-N 3-[6-(2-chlorophenyl)pyrido[2,3-b][1,4]benzodiazepin-11-yl]-n,n-dimethylpropan-1-amine Chemical compound N=1C2=CC=CN=C2N(CCCN(C)C)C2=CC=CC=C2C=1C1=CC=CC=C1Cl QHTMOFKGJVMAAW-UHFFFAOYSA-N 0.000 description 1
- QKXFOKQWCWIWBH-UHFFFAOYSA-N 3-[6-(2-ethylphenyl)pyrido[2,3-b][1,4]benzodiazepin-11-yl]-n,n-dimethylpropan-1-amine Chemical compound CCC1=CC=CC=C1C1=NC2=CC=CN=C2N(CCCN(C)C)C2=CC=CC=C12 QKXFOKQWCWIWBH-UHFFFAOYSA-N 0.000 description 1
- WYPIJADKVYJQHZ-UHFFFAOYSA-N 3-[6-(4-bromophenyl)pyrido[2,3-b][1,4]benzodiazepin-11-yl]-n,n-dimethylpropan-1-amine Chemical compound N=1C2=CC=CN=C2N(CCCN(C)C)C2=CC=CC=C2C=1C1=CC=C(Br)C=C1 WYPIJADKVYJQHZ-UHFFFAOYSA-N 0.000 description 1
- CGZOELPTETZMTJ-UHFFFAOYSA-N 3-[6-(4-methoxyphenyl)pyrido[2,3-b][1,4]benzodiazepin-11-yl]-n,n-dimethylpropan-1-amine Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=CN=C2N(CCCN(C)C)C2=CC=CC=C12 CGZOELPTETZMTJ-UHFFFAOYSA-N 0.000 description 1
- AGWBEYQZGBQXLL-UHFFFAOYSA-N 3-chloro-2-methylpyridin-4-amine Chemical compound CC1=NC=CC(N)=C1Cl AGWBEYQZGBQXLL-UHFFFAOYSA-N 0.000 description 1
- AMWFMUVCKSXNHV-UHFFFAOYSA-N 3-chloro-4,6-dimethylpyridin-2-amine Chemical compound CC1=CC(C)=C(Cl)C(N)=N1 AMWFMUVCKSXNHV-UHFFFAOYSA-N 0.000 description 1
- COTHZSSUQJRBQH-UHFFFAOYSA-N 3-chloro-5-methylpyridin-2-amine Chemical compound CC1=CN=C(N)C(Cl)=C1 COTHZSSUQJRBQH-UHFFFAOYSA-N 0.000 description 1
- UGXACBBAXFABGT-UHFFFAOYSA-N 3-chloro-n,n,2-trimethylpropan-1-amine Chemical compound ClCC(C)CN(C)C UGXACBBAXFABGT-UHFFFAOYSA-N 0.000 description 1
- HRFUHSXZAFNXAI-UHFFFAOYSA-N 3-chloropropyl(methyl)carbamic acid Chemical compound OC(=O)N(C)CCCCl HRFUHSXZAFNXAI-UHFFFAOYSA-N 0.000 description 1
- KJBKPRMEMJKXDV-UHFFFAOYSA-N 3-chloropyridin-4-amine Chemical compound NC1=CC=NC=C1Cl KJBKPRMEMJKXDV-UHFFFAOYSA-N 0.000 description 1
- RBIGKSZIQCTIJF-UHFFFAOYSA-N 3-formylthiophene Chemical compound O=CC=1C=CSC=1 RBIGKSZIQCTIJF-UHFFFAOYSA-N 0.000 description 1
- PMPUGNOKQNEGQZ-UHFFFAOYSA-N 3-methoxy-6-phenyl-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound N=1C2=CC(OC)=CN=C2NC2=CC=CC=C2C=1C1=CC=CC=C1 PMPUGNOKQNEGQZ-UHFFFAOYSA-N 0.000 description 1
- SNFXKHJDUXYNSU-UHFFFAOYSA-N 4-(3-chlorophenyl)morpholine Chemical compound ClC1=CC=CC(N2CCOCC2)=C1 SNFXKHJDUXYNSU-UHFFFAOYSA-N 0.000 description 1
- PQECODMSWJOUAT-UHFFFAOYSA-N 4-(3-chloropropyl)morpholine;hydrochloride Chemical compound [Cl-].ClCCC[NH+]1CCOCC1 PQECODMSWJOUAT-UHFFFAOYSA-N 0.000 description 1
- RBHLFWNKEWLHBP-UHFFFAOYSA-N 4-(4-aminophenyl)butanoic acid Chemical compound NC1=CC=C(CCCC(O)=O)C=C1 RBHLFWNKEWLHBP-UHFFFAOYSA-N 0.000 description 1
- BIGIJBBFOOLCJA-UHFFFAOYSA-N 4-chloro-2-methylpyridin-3-amine Chemical compound CC1=NC=CC(Cl)=C1N BIGIJBBFOOLCJA-UHFFFAOYSA-N 0.000 description 1
- KUORZWTVGDBHBR-UHFFFAOYSA-N 6-(4-methylphenyl)-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C1=CC(C)=CC=C1C1=NC2=CC=CN=C2NC2=CC=CC=C12 KUORZWTVGDBHBR-UHFFFAOYSA-N 0.000 description 1
- ZPVPKKMRMPSDHU-UHFFFAOYSA-N 6-(4-nitrophenyl)-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=NC2=CC=CN=C2NC2=CC=CC=C12 ZPVPKKMRMPSDHU-UHFFFAOYSA-N 0.000 description 1
- AVRIVKIHQPGPCY-UHFFFAOYSA-N 6-(4-propan-2-ylphenyl)-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C1=CC(C(C)C)=CC=C1C1=NC2=CC=CN=C2NC2=CC=CC=C12 AVRIVKIHQPGPCY-UHFFFAOYSA-N 0.000 description 1
- FUCSZMUFPDUOJB-UHFFFAOYSA-N 6-[3-(trifluoromethyl)phenyl]-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound FC(F)(F)C1=CC=CC(C=2C3=CC=CC=C3NC3=NC=CC=C3N=2)=C1 FUCSZMUFPDUOJB-UHFFFAOYSA-N 0.000 description 1
- AVDSUSDQLKKKDN-UHFFFAOYSA-N 6-[4-(trifluoromethyl)phenyl]-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=NC2=CC=CN=C2NC2=CC=CC=C12 AVDSUSDQLKKKDN-UHFFFAOYSA-N 0.000 description 1
- KCTGNLJETPHOEQ-UHFFFAOYSA-N 6-phenyl-11h-pyrido[3,2-b][1,4]benzodiazepine Chemical compound C12=CC=CC=C2NC2=CC=CN=C2N=C1C1=CC=CC=C1 KCTGNLJETPHOEQ-UHFFFAOYSA-N 0.000 description 1
- VXVMCDQJCPRVCB-UHFFFAOYSA-N 6-phenyl-11h-pyrido[3,4-b][1,4]benzodiazepine Chemical compound N=1C2=CC=NC=C2NC2=CC=CC=C2C=1C1=CC=CC=C1 VXVMCDQJCPRVCB-UHFFFAOYSA-N 0.000 description 1
- LCVDXRGWCRJATG-UHFFFAOYSA-N 6-phenyl-9-(trifluoromethyl)-11h-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C=1C(C(F)(F)F)=CC=C2C=1NC1=NC=CC=C1N=C2C1=CC=CC=C1 LCVDXRGWCRJATG-UHFFFAOYSA-N 0.000 description 1
- NUJKMTFESQGLLL-UHFFFAOYSA-N 6-pyridin-3-yl-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound N=1C2=CC=CN=C2NC2=CC=CC=C2C=1C1=CC=CN=C1 NUJKMTFESQGLLL-UHFFFAOYSA-N 0.000 description 1
- VILUYDOHRGAWJZ-UHFFFAOYSA-N 8-chloro-6-(2-nitrophenyl)-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound [O-][N+](=O)C1=CC=CC=C1C1=NC2=CC=CN=C2NC2=CC=C(Cl)C=C12 VILUYDOHRGAWJZ-UHFFFAOYSA-N 0.000 description 1
- URHJOVSPGNSBCD-UHFFFAOYSA-N 8-methyl-6-phenyl-11H-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C12=CC(C)=CC=C2NC2=NC=CC=C2N=C1C1=CC=CC=C1 URHJOVSPGNSBCD-UHFFFAOYSA-N 0.000 description 1
- SPKBRIIYTVKGPQ-UHFFFAOYSA-N 9-chloro-6-phenyl-11h-pyrido[2,3-b][1,4]benzodiazepine Chemical compound C=1C(Cl)=CC=C2C=1NC1=NC=CC=C1N=C2C1=CC=CC=C1 SPKBRIIYTVKGPQ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 101100048447 Caenorhabditis elegans unc-4 gene Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102100025597 Caspase-4 Human genes 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 101100273284 Homo sapiens CASP4 gene Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 101100490437 Mus musculus Acvrl1 gene Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- SJTQSCOTRZINGB-UHFFFAOYSA-N [2-[(2-amino-4,6-dimethylpyridin-3-yl)amino]phenyl]-phenylmethanone Chemical compound NC1=NC(C)=CC(C)=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1 SJTQSCOTRZINGB-UHFFFAOYSA-N 0.000 description 1
- JXKHIFIKFYTTLK-UHFFFAOYSA-N [2-[(2-aminopyridin-3-yl)amino]phenyl]-phenylmethanone Chemical compound NC1=NC=CC=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1 JXKHIFIKFYTTLK-UHFFFAOYSA-N 0.000 description 1
- OOLHOTFXJZEIRP-UHFFFAOYSA-N [2-[(3-amino-4-methylpyridin-2-yl)amino]phenyl]-phenylmethanone Chemical compound CC1=CC=NC(NC=2C(=CC=CC=2)C(=O)C=2C=CC=CC=2)=C1N OOLHOTFXJZEIRP-UHFFFAOYSA-N 0.000 description 1
- LDYWBJKBLXKDAG-UHFFFAOYSA-N [2-[(3-amino-5,6-dimethylpyridin-2-yl)amino]phenyl]-phenylmethanone Chemical compound N1=C(C)C(C)=CC(N)=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1 LDYWBJKBLXKDAG-UHFFFAOYSA-N 0.000 description 1
- ZEMSNECKDXZYBH-UHFFFAOYSA-N [2-[(3-amino-5-methoxypyridin-2-yl)amino]phenyl]-phenylmethanone Chemical compound NC1=CC(OC)=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1 ZEMSNECKDXZYBH-UHFFFAOYSA-N 0.000 description 1
- NPWLJSUEQCDMGA-UHFFFAOYSA-N [2-[(3-amino-6-methylpyridin-2-yl)amino]phenyl]-phenylmethanone Chemical compound CC1=CC=C(N)C(NC=2C(=CC=CC=2)C(=O)C=2C=CC=CC=2)=N1 NPWLJSUEQCDMGA-UHFFFAOYSA-N 0.000 description 1
- OKCUQANWJTVKIE-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-3-methylphenyl]-phenylmethanone Chemical compound N=1C=CC=C(N)C=1NC=1C(C)=CC=CC=1C(=O)C1=CC=CC=C1 OKCUQANWJTVKIE-UHFFFAOYSA-N 0.000 description 1
- LPLRGPOMLOOSEN-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-4-bromophenyl]-phenylmethanone Chemical compound NC1=CC=CN=C1NC1=CC(Br)=CC=C1C(=O)C1=CC=CC=C1 LPLRGPOMLOOSEN-UHFFFAOYSA-N 0.000 description 1
- NCVDGWAAFROCBX-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-4-chlorophenyl]-phenylmethanone Chemical compound NC1=CC=CN=C1NC1=CC(Cl)=CC=C1C(=O)C1=CC=CC=C1 NCVDGWAAFROCBX-UHFFFAOYSA-N 0.000 description 1
- KNURXOWJKSRTTC-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-4-ethoxyphenyl]-phenylmethanone Chemical compound N=1C=CC=C(N)C=1NC1=CC(OCC)=CC=C1C(=O)C1=CC=CC=C1 KNURXOWJKSRTTC-UHFFFAOYSA-N 0.000 description 1
- JFNQCNAUPSGETA-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-4-ethylphenyl]-phenylmethanone Chemical compound N=1C=CC=C(N)C=1NC1=CC(CC)=CC=C1C(=O)C1=CC=CC=C1 JFNQCNAUPSGETA-UHFFFAOYSA-N 0.000 description 1
- BMMKJJWTHVEFOB-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-4-fluorophenyl]-phenylmethanone Chemical compound NC1=CC=CN=C1NC1=CC(F)=CC=C1C(=O)C1=CC=CC=C1 BMMKJJWTHVEFOB-UHFFFAOYSA-N 0.000 description 1
- OLMBNJAACAPHOM-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-4-methoxyphenyl]-phenylmethanone Chemical compound N=1C=CC=C(N)C=1NC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 OLMBNJAACAPHOM-UHFFFAOYSA-N 0.000 description 1
- NLRHEQNJABUKDI-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-5-chlorophenyl]-phenylmethanone Chemical compound NC1=CC=CN=C1NC1=CC=C(Cl)C=C1C(=O)C1=CC=CC=C1 NLRHEQNJABUKDI-UHFFFAOYSA-N 0.000 description 1
- KVGPOAYOAQAOOZ-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]-5-methylphenyl]-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1=CC(C)=CC=C1NC1=NC=CC=C1N KVGPOAYOAQAOOZ-UHFFFAOYSA-N 0.000 description 1
- NJZQMXHBCNCDLR-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(2-methoxyphenyl)methanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC=CC=C1NC1=NC=CC=C1N NJZQMXHBCNCDLR-UHFFFAOYSA-N 0.000 description 1
- SQSVVHZISPLMGJ-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(3-ethoxyphenyl)methanone Chemical compound CCOC1=CC=CC(C(=O)C=2C(=CC=CC=2)NC=2C(=CC=CN=2)N)=C1 SQSVVHZISPLMGJ-UHFFFAOYSA-N 0.000 description 1
- MVGZNJBYLCBMQG-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(3-fluorophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CC(F)=C1 MVGZNJBYLCBMQG-UHFFFAOYSA-N 0.000 description 1
- QQSJSJBSDAWJJS-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(3-methylphenyl)methanone Chemical compound CC1=CC=CC(C(=O)C=2C(=CC=CC=2)NC=2C(=CC=CN=2)N)=C1 QQSJSJBSDAWJJS-UHFFFAOYSA-N 0.000 description 1
- ALNYFJCONXXPNA-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-(4-fluorophenyl)methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=C(F)C=C1 ALNYFJCONXXPNA-UHFFFAOYSA-N 0.000 description 1
- YTALBQCYRLPVLC-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-[4-(trifluoromethyl)phenyl]methanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=C(C(F)(F)F)C=C1 YTALBQCYRLPVLC-UHFFFAOYSA-N 0.000 description 1
- JKOYHSGPAKBGAG-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-phenylmethanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1 JKOYHSGPAKBGAG-UHFFFAOYSA-N 0.000 description 1
- QZRDUNYPEWBMEW-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-thiophen-2-ylmethanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CC=CS1 QZRDUNYPEWBMEW-UHFFFAOYSA-N 0.000 description 1
- BYQIHYWZVSIGFL-UHFFFAOYSA-N [2-[(3-aminopyridin-2-yl)amino]phenyl]-thiophen-3-ylmethanone Chemical compound NC1=CC=CN=C1NC1=CC=CC=C1C(=O)C1=CSC=C1 BYQIHYWZVSIGFL-UHFFFAOYSA-N 0.000 description 1
- VQSFSBVCCSVAES-UHFFFAOYSA-N [2-[(3-aminopyridin-4-yl)amino]phenyl]-phenylmethanone Chemical compound NC1=CN=CC=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1 VQSFSBVCCSVAES-UHFFFAOYSA-N 0.000 description 1
- YBEPEAVHTXMZRZ-UHFFFAOYSA-N [2-[(4-amino-5-methylpyridin-3-yl)amino]phenyl]-phenylmethanone Chemical compound CC1=CN=CC(NC=2C(=CC=CC=2)C(=O)C=2C=CC=CC=2)=C1N YBEPEAVHTXMZRZ-UHFFFAOYSA-N 0.000 description 1
- AOVHVNOAARRNKM-UHFFFAOYSA-N [2-[(4-amino-6-methylpyridin-3-yl)amino]phenyl]-phenylmethanone Chemical compound C1=NC(C)=CC(N)=C1NC1=CC=CC=C1C(=O)C1=CC=CC=C1 AOVHVNOAARRNKM-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- TXHIDIHEXDFONW-UHFFFAOYSA-N benzene;propan-2-one Chemical compound CC(C)=O.C1=CC=CC=C1 TXHIDIHEXDFONW-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000004799 bromophenyl group Chemical group 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 231100000457 cardiotoxic Toxicity 0.000 description 1
- 230000001451 cardiotoxic effect Effects 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical group Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 239000011874 heated mixture Substances 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- QMEZUZOCLYUADC-UHFFFAOYSA-N hydrate;dihydrochloride Chemical compound O.Cl.Cl QMEZUZOCLYUADC-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- OVWYEQOVUDKZNU-UHFFFAOYSA-N m-tolualdehyde Chemical compound CC1=CC=CC(C=O)=C1 OVWYEQOVUDKZNU-UHFFFAOYSA-N 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- SSKCKXFBESPLGT-UHFFFAOYSA-N n,n-dimethyl-2-(6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)ethanamine Chemical compound N=1C2=CC=CN=C2N(CCN(C)C)C2=CC=CC=C2C=1C1=CC=CC=C1 SSKCKXFBESPLGT-UHFFFAOYSA-N 0.000 description 1
- SEOPMMYINYCSJG-UHFFFAOYSA-N n,n-dimethyl-3-(2-methyl-6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)propan-1-amine Chemical compound N=1C2=CC=C(C)N=C2N(CCCN(C)C)C2=CC=CC=C2C=1C1=CC=CC=C1 SEOPMMYINYCSJG-UHFFFAOYSA-N 0.000 description 1
- XMQQDESUZMYVPN-UHFFFAOYSA-N n,n-dimethyl-3-(3-methyl-6-phenylpyrido[2,3-b][1,4]benzodiazepin-11-yl)propan-1-amine Chemical compound N=1C2=CC(C)=CN=C2N(CCCN(C)C)C2=CC=CC=C2C=1C1=CC=CC=C1 XMQQDESUZMYVPN-UHFFFAOYSA-N 0.000 description 1
- OIVGIIWPZYHINE-UHFFFAOYSA-N n,n-dimethyl-3-(6-phenyl-5,6-dihydropyrido[2,3-b][1,4]benzodiazepin-11-yl)propan-1-amine Chemical compound N1C2=CC=CN=C2N(CCCN(C)C)C2=CC=CC=C2C1C1=CC=CC=C1 OIVGIIWPZYHINE-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- UJTMLNARSPORHR-UHFFFAOYSA-N oc2h5 Chemical compound C=C=[O+] UJTMLNARSPORHR-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30508081A | 1981-09-24 | 1981-09-24 | |
| US30508081 | 1981-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU83865A1 true LU83865A1 (fr) | 1983-09-02 |
Family
ID=23179241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU83865A LU83865A1 (fr) | 1981-09-24 | 1982-01-05 | Pyrido(1,4)benzodiazepines phenyl-substituees et leurs intermediaires,utiles comme medicaments antidepresseurs |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS5865290A (no) |
| KR (1) | KR890000764B1 (no) |
| BE (1) | BE891666A (no) |
| CA (1) | CA1199324A (no) |
| CH (1) | CH651833A5 (no) |
| DE (1) | DE3150522A1 (no) |
| DK (3) | DK186282A (no) |
| EG (1) | EG15904A (no) |
| ES (6) | ES507971A0 (no) |
| FI (1) | FI71935C (no) |
| FR (1) | FR2515183B1 (no) |
| GR (1) | GR78473B (no) |
| HU (2) | HU189426B (no) |
| IE (1) | IE52493B1 (no) |
| IL (1) | IL64284A (no) |
| IN (1) | IN156080B (no) |
| IT (1) | IT1146728B (no) |
| LU (1) | LU83865A1 (no) |
| NL (1) | NL8200549A (no) |
| NO (1) | NO157700C (no) |
| NZ (1) | NZ198999A (no) |
| PH (2) | PH17847A (no) |
| PL (6) | PL143322B1 (no) |
| PT (1) | PT74286B (no) |
| SE (2) | SE448629B (no) |
| YU (1) | YU46128B (no) |
| ZA (1) | ZA817866B (no) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3825549A (en) * | 1972-10-24 | 1974-07-23 | Squibb & Sons Inc | Certain dihydropyrido(2,1-b)(1,3)benzodi-azepines and benzodiazocines |
| DE2424811C3 (de) * | 1974-05-22 | 1981-08-20 | Dr. Karl Thomae Gmbh, 7950 Biberach | Pyrido-benzodiazepinone, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| SE422799B (sv) * | 1975-05-28 | 1982-03-29 | Merck & Co Inc | Analogiforfarande for framstellning av 1,3-dihydroimidazo (4,5-b)pyridin-2-oner |
-
1981
- 1981-11-05 SE SE8106573A patent/SE448629B/sv not_active IP Right Cessation
- 1981-11-12 NO NO813839A patent/NO157700C/no unknown
- 1981-11-12 ZA ZA817866A patent/ZA817866B/xx unknown
- 1981-11-13 IL IL64284A patent/IL64284A/xx unknown
- 1981-11-13 IN IN1261/CAL/81A patent/IN156080B/en unknown
- 1981-11-17 GR GR66553A patent/GR78473B/el unknown
- 1981-11-18 PH PH26507A patent/PH17847A/en unknown
- 1981-11-25 IE IE2769/81A patent/IE52493B1/en unknown
- 1981-12-09 IT IT68605/81A patent/IT1146728B/it active
- 1981-12-10 FI FI813976A patent/FI71935C/fi not_active IP Right Cessation
- 1981-12-15 ES ES507971A patent/ES507971A0/es active Granted
- 1981-12-15 HU HU843212A patent/HU189426B/hu not_active IP Right Cessation
- 1981-12-15 HU HU813777A patent/HU187393B/hu not_active IP Right Cessation
- 1981-12-21 DE DE19813150522 patent/DE3150522A1/de not_active Withdrawn
- 1981-12-23 PL PL1981253540A patent/PL143322B1/pl unknown
- 1981-12-23 PL PL1981234426A patent/PL138859B1/pl unknown
- 1981-12-23 PL PL1981253539A patent/PL143597B1/pl unknown
- 1981-12-23 PL PL1981241409A patent/PL139381B1/pl unknown
- 1981-12-23 FR FR8124111A patent/FR2515183B1/fr not_active Expired
- 1981-12-23 PL PL1981241410A patent/PL137068B1/pl unknown
- 1981-12-23 PL PL1981253538A patent/PL143596B1/pl unknown
- 1981-12-30 BE BE0/206969A patent/BE891666A/fr not_active IP Right Cessation
-
1982
- 1982-01-05 LU LU83865A patent/LU83865A1/fr unknown
- 1982-01-12 EG EG11/82A patent/EG15904A/xx active
- 1982-01-14 JP JP57004813A patent/JPS5865290A/ja active Pending
- 1982-01-15 PT PT74286A patent/PT74286B/pt unknown
- 1982-01-18 CA CA000394367A patent/CA1199324A/en not_active Expired
- 1982-02-02 KR KR8200420A patent/KR890000764B1/ko not_active Expired
- 1982-02-12 NL NL8200549A patent/NL8200549A/nl not_active Application Discontinuation
- 1982-02-18 NZ NZ198999A patent/NZ198999A/en unknown
- 1982-03-23 YU YU62582A patent/YU46128B/sh unknown
- 1982-04-15 CH CH2288/82A patent/CH651833A5/fr not_active IP Right Cessation
- 1982-04-26 DK DK186282A patent/DK186282A/da not_active Application Discontinuation
- 1982-09-29 ES ES516052A patent/ES516052A0/es active Granted
- 1982-09-29 ES ES516051A patent/ES516051A0/es active Granted
-
1983
- 1983-10-19 ES ES526563A patent/ES8604531A1/es not_active Expired
- 1983-10-19 ES ES526562A patent/ES526562A0/es active Granted
-
1984
- 1984-08-17 PH PH31120A patent/PH20536A/en unknown
-
1985
- 1985-05-21 ES ES543328A patent/ES8607726A1/es not_active Expired
-
1986
- 1986-02-17 SE SE8600688A patent/SE455305B/sv not_active IP Right Cessation
-
1987
- 1987-08-03 DK DK403387A patent/DK403387A/da not_active Application Discontinuation
- 1987-08-03 DK DK403487A patent/DK403487A/da not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69609602T2 (de) | Pyrazolderivate und verfahren zu deren herstellung | |
| JPWO1994028901A1 (ja) | アミノ酸誘導体 | |
| JPH09500107A (ja) | ２−，３−，４−，５−，６−，７−，８−，９−および／または１０−置換ジベンズオキサゼピンおよびジベンズチアゼピン化合物、薬剤組成物および使用法 | |
| FR2644456A1 (fr) | Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent | |
| KR910009934B1 (ko) | 카르바모일-2-피롤리디논 화합물 | |
| US4447361A (en) | Aryl substituted pyrido[1,4]benzodiazepines | |
| LU83865A1 (fr) | Pyrido(1,4)benzodiazepines phenyl-substituees et leurs intermediaires,utiles comme medicaments antidepresseurs | |
| KR850000452B1 (ko) | 카바모일옥시아미노-1, 4-벤조디아제핀의 제조방법 | |
| KR870000279B1 (ko) | 피리도 [1,4] 벤조디아제핀 및 [2-[(니트로피리디닐) 아미노]페닐] 아릴메타논의 제조방법 | |
| NZ199610A (en) | Tricyclic pyrrole derivatives | |
| US4311700A (en) | Pyrimidobenzodiazepinones, their use and medicaments containing them | |
| JPH04221386A (ja) | ４Ｈ−ピロロ［１，２−ａ］チエノ［２，３−ｆ］［１，４］ジアゼピンの新規誘導体、それらの製造方法及びこれらを含有する医薬品組成物 | |
| US3879392A (en) | Pyrido(4,3-c)pyridazine compounds | |
| EP0076017B1 (en) | Phenyl substituted pyrido(1,4)benzodiazepines and intermediates therefor | |
| AU662730B2 (en) | Neuroprotectant agents | |
| US4556667A (en) | Aryl substituted pyrido[1,4]benzodiazepines and their use as antidepressives | |
| PT91054A (pt) | Processo para a preparacao de derivados de 5,6,7,8-tetrahidro-4h-isoxazolo {4,5-d} azepin-3-o1 (thaz) e de composicoes farmaceuticas que os contem | |
| US4495183A (en) | Aryl substituted pyrido[1,4]benzodiazepines for treatment of depression | |
| EP0172692B1 (en) | Hexahydroindolizine compounds, pharmaceutical compositions and methods and intermediates | |
| US4668675A (en) | 2-[(amino-pyridinyl)amine]phenyl]aryl methanones, their thioxomethyl, ketal or thioketal analogs | |
| WO2025140637A1 (zh) | 一种tdg抑制剂化合物及其用途 | |
| HK40121692A (zh) | 一种tdg抑制剂化合物及其用途 | |
| NL8105892A (nl) | Werkwijze om depressies te behandelen met 5-(aminoalkyl)-11-fenyl-5h-dibenzob,e1,4 diazepinen. |